Dr. Lavanya Yohanathan, MD

Dr. Yohanathan practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Yohanathan's NPI, 1467740845, was assigned on July 19, 2011. Dr. Yohanathan holds Michigan license 4301504316.

Dr. Yohanathan's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Yohanathan's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Yohanathan is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Yohanathan to 3 more hospitals, 3 group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yohanathan practices, 9 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Yohanathan's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Yohanathan's licenses on file in 3 states: Michigan, Minnesota and Rhode Island.

CMS data shows 187 Medicare services from Dr. Yohanathan across 4 procedure codes in 2024, for 113 Medicare patients. Medicare paid $19,899 for them.

CMS counts 113 Medicare patients who saw Dr. Yohanathan in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yohanathan's median patient age at 69, with 57% women.

In 2024, Dr. Yohanathan wrote 45 Medicare Part D claims for 23 patients. 56% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $13,711 in total drug cost. In 2022, CMS named 43 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Yohanathan for performance year 2024, reported as part of a group. Dr. Yohanathan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yohanathan as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Yohanathan, published from 2011 to 2023. 2020 was the busiest year, with 7. The most frequent topics are Pancreatic Neoplasms, Lymphatic Metastasis and Stomach Neoplasms. Dr. Yohanathan has published most often in Gastric Cancer. Dr. Yohanathan's most frequent co-authors are David M. Nagorney, MD, Rory L. Smoot, MD and Alice Chia-Chi Wei, MD.

CMS Open Payments shows 77 general payments to Dr. Yohanathan from 11 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 40% of the total. Medtronic, Inc. paid the most, $4,555.